ADMSC-derived exosomes promote diabetic wound healing by inhibiting neutrophil extracellular traps formation through delivering miR-92a-1-5p.
Li W., Zhang H., Bai P., Wang H., Hou F., Zhou Z.
Animal Study on Diabetic Foot, Chronic Wound, published in Arch Biochem Biophys (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Arch Biochem Biophys (2026)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 41628774
- DOI
- 10.1016/j.abb.2026.110755
Abstract (original English)
Adipose-derived mesenchymal stem cell-derived exosomes (ADMSC-ex) have demonstrated remarkable efficacy in promoting diabetic wound healing. However, the underlying mechanisms remain largely elusive. In this study, we showed the healing process of skin wounds in diabetic rats was notably delayed, but this delay was mitigated by the administration of ADMSCs-ex. Neutrophil extracellular traps (NETs) formation was significantly upregulated in the skin wounds from the diabetes group. ADMSCs-ex administration attenuated this upregulation. The upregulation of S100A9 was confirmed in wound tissues from diabetic rats, as well as neutrophils induced by high glucose. ADMSCs-ex administration significantly reduced S100A9 protein expression via delivering miR-92a-1-5p in vitro. In vivo study showed that miR-92a-1-5p knockdown obstructed the promotional effect of ADMSCs-ex on diabetic wound healing and NETs formation. In conclusion, this study provides evidence that ADMSCs-ex accelerate diabetic wounds healing via a conserved miR-92a-1-5p/S100A9 pathway. These findings suggest that these exosomes loaded with miR-92a-1-5p may represent a promising therapeutic approach for the management of impaired healing of diabetic wounds.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations